BEGIN:VCALENDAR
PRODID: University of Exeter
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20150323T150000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20150323T150000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
END:STANDARD
END:VTIMEZONE
METHOD:PUBLISH
BEGIN:VEVENT
SUMMARY; CHARSET=UTF-8 :"Ethical harmonization across space: logistic and regulatory issues in implementing a multi-national clinical trial" - Prof Christine Hauskeller & Nicole Baur (UoE)
UID:exeter_event_2955
URL:http://www.exeter.ac.uk/events/details/?event=2955
DTSTART;VALUE=DATE:20150323T150000
DTEND;VALUE=DATE:20150323T163000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
ORGANIZER: MAILTO:
ATTACH: http://www.exeter.ac.uk/events/details/?event=2955
DTSTAMP:20150217T114253
LOCATION:Byrne House
DESCRIPTION; CHARSET=UTF-8 :In this talk we report findings from an empirical investigation of the process in which a stem cell clinical trial is being implemented across 10 European countries. As part of a clinical trial team, we had the unique opportunity to study implementation – including its events and problems - while it happened. Obstacles for swift patient recruitment across clinical sites arose for a variety of reasons, but most are related to the minute standardization of practice which is the basis for the scientific approach in medicine that identifies clinical trials as ultimate evidence for clinical efficacy. We identified differences in resource management and in locally entrenched daily routines of patient care, but also in the practical implementation of regulations and insurance requirements, for example, which as such relate back to specific understandings of best practice in clinical care. Our findings show that the policies developed to harmonise medical practice and clinical trials in Europe can lead to serious delays before patient recruitment even starts. We especially focus on problems with the logistics and technological requirements following European Medicines Agency (EMA) regulations and the effects of the Voluntary Harmonisation Procedure (VHP), a protocol aimed at simplifying multinational ethics approval of general agreements which depend on both trust and coherence in other policies.http://www.exeter.ac.uk/events/details/?event=2955
SEQUENCE:0
PRIORITY:5
CLASS:
STATUS:CONFIRMED
TRANSP:TRANSPARENT
X-MICROSOFT-CDO-IMPORTANCE:1
X-Microsoft-CDO-BUSYSTATUS:FREE
X-MICROSOFT-CDO-INSTTYPE:0
X-Microsoft-CDO-INTENDEDSTATUS:FREE
END:VEVENT
END:VCALENDAR